Stockreport

How Investors May Respond To Takeda Pharmaceutical (TSE:4502) Exiting Cell Therapy to Refocus R&D Priorities [Yahoo! Finance]

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of)  (TAK) 
PDF its Massachusetts R&D facility and a forthcoming impairment charge related to its cell therapy technology. This move is part of a broader portfolio refocusing, with th [Read more]